Methylisothiazolinone sensitisation in New Zealand is decreasing

CONCLUSION: Both sensitisation and ACD to MI appear to be decreasing, likely secondary to changes in product compounding due to stricter concentration limits internationally. We recommend New Zealand adopt lower MI concentration limits for cosmetics to match the limits of Australia and Europe.PMID:38706204 | DOI:10.1111/ajd.14301
Source: The Australasian Journal of Dermatology - Category: Dermatology Authors: Source Type: research